- Home
- NLSP vs AMST Comparison
NLSP vs AMST Comparison
Compare NLSP & AMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NLSP
- AMST
- Stock Information
- Founded
- NLSP 2015
- AMST 2017
- Country
- NLSP Switzerland
- AMST United States
- Employees
- NLSP N/A
- AMST N/A
- Industry
- NLSP Biotechnology: Pharmaceutical Preparations
- AMST Computer Software: Prepackaged Software
- Sector
- NLSP Health Care
- AMST Technology
- Exchange
- NLSP Nasdaq
- AMST Nasdaq
- Market Cap
- NLSP 12.4M
- AMST 9.5M
- IPO Year
- NLSP 2021
- AMST 2020
- Fundamental
- Price
- NLSP $2.31
- AMST $3.32
- Analyst Decision
- NLSP
- AMST
- Analyst Count
- NLSP 0
- AMST 0
- Target Price
- NLSP N/A
- AMST N/A
- AVG Volume (30 Days)
- NLSP 378.8K
- AMST 91.6K
- Earning Date
- NLSP 07-15-2025
- AMST 05-15-2025
- Dividend Yield
- NLSP N/A
- AMST N/A
- EPS Growth
- NLSP N/A
- AMST N/A
- EPS
- NLSP N/A
- AMST N/A
- Revenue
- NLSP N/A
- AMST $82,544.00
- Revenue This Year
- NLSP N/A
- AMST N/A
- Revenue Next Year
- NLSP N/A
- AMST N/A
- P/E Ratio
- NLSP N/A
- AMST N/A
- Revenue Growth
- NLSP N/A
- AMST N/A
- 52 Week Low
- NLSP $1.30
- AMST $2.00
- 52 Week High
- NLSP $15.59
- AMST $6.27
- Technical
- Relative Strength Index (RSI)
- NLSP 48.87
- AMST 64.05
- Support Level
- NLSP $2.20
- AMST $2.51
- Resistance Level
- NLSP $3.08
- AMST $3.77
- Average True Range (ATR)
- NLSP 0.25
- AMST 0.21
- MACD
- NLSP -0.05
- AMST 0.08
- Stochastic Oscillator
- NLSP 16.36
- AMST 64.17
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.
About AMST Amesite Inc.
Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high-performance and scalable online products for schools and businesses. The company helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology driven by AI and offers a constellation of services that help partners implement new programs, and improve existing ones. Its customers are Enterprises, universities, and K-12 schools.